Navigation Links
Ultra-fast, ultra-intense laser has clean-cut advantage
Date:3/13/2008

COLUMBIA, Mo. Many people equate lasers with a sci-fi battle in a galaxy far, far away or, closer to home, with grocery store scanners and compact disc players. However, an ultra-fast, ultra-intense laser, or UUL, with laser pulse durations of one quadrillionth of a second, otherwise known as one femtosecond, could change cancer treatments, dentistry procedures, precision metal cutting, and joint implant surgeries.

The femtosecond laser has now entered the era of applications. It used to be a novelty, a fantasy, said University of Missouri researcher Robert Tzou, the James C. Dowell professor and chairman of the department of Mechanical and Aerospace Engineering. We are currently targeting the areas of life-science and bio-medicine.

What makes the femtosecond laser different from other lasers is its unique capacity to interact with its target without transferring heat to the area surrounding its mark. The intensity of the power gets the job done while the speed ensures heat does not spread. Results are clean cuts, strong welds and precision destruction of very small targets, such as cancer cells, with no injury to surrounding materials. Tzou hopes that the laser would essentially eliminate the need for harmful chemical therapy used in cancer treatments.

If we have a way to use the lasers to kill cancer cells without even touching the surrounding healthy cells, that is a tremendous benefit to the patient, Tzou said. Basically, the patient leaves the clinic immediately after treatment with no side effects or damage. The high precision and high efficiency of the UUL allows for immediate results.

Practical applications of this type of laser also include, but arent limited to, the ability to create super-clean channels in a silicon chip. That process can allow doctors to analyze blood one cell at a time as cells flow through the channel. The laser can be used in surgery to make more precise incisions that heal faster and ca
'/>"/>

Contact: Bryan E. Jones
jonesbry@missouri.edu
573-882-9144
University of Missouri-Columbia
Source:Eurekalert  

1

GOOD

Page: 1 2

Related medicine news :

1. HOYA ConBio Partners With Advanced Laser Training to Offer Complementary Laser Certification Course in Dentistry
2. The DOT CO2 Fractional: The Next Step in Laser Skin Resurfacing
3. Laser Screen Detects Diseases in Breath
4. American Laser Centers Names Bill Van Huis as Chief Revenue Officer
5. Scientists using laser light to detect potential diseases via breath samples, says new study
6. Laser light may be able to detect diseases on the breath
7. UT Southwestern plastic surgeons deploy new carbon dioxide-based fractional laser
8. Integrated Laser Therapies Launches, Offers Low-power, Therapeutic Laser Devices and Training for Therapists and Consumers
9. Keep Father Time From Marching On: New Laser Treatments Offer Gentle and Effective Skin Resurfacing in a Flash
10. Acne And Rosacea Getting You Down? Laser, Light And Cosmetic Treatments Give Patients A Much-Needed Boost
11. Alma(TM) Lasers to Debut Five New Products at the 66th Annual Meeting of the American Academy of Dermatology
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Ultra-fast, ultra-intense laser has clean-cut advantage
Ultra-fast, ultra-intense laser has clean-cut advantage
Breaking Medicine News(10 mins):Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 2Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 3Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 4Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 5Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 6Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 7Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 8Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 9Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 10Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 11Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 12Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 13Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 14Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 15Health News:China Cord Blood Corporation Announces Results for the Quarter and Six Months Ended September 30, 2009 16Health News:New Board Gains Control of U.S. Shanghai Chemical Corporation 2Health News:Surgery on beating heart thanks to robotic helping hand 2Health News:Repeat of Fire Tragedy in Chicago High-Rise Should Have Been Prevented 2Health News:Repeat of Fire Tragedy in Chicago High-Rise Should Have Been Prevented 3Health News:Repeat of Fire Tragedy in Chicago High-Rise Should Have Been Prevented 4Health News:Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 2Health News:Planview and Carestream Health Discuss the Intelligent Portfolio on December 17 Webinar 3
Other Medicine Technology:Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 2Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 3Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 4Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 5Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 6Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 7Shire Announces Positive Results of Studies With Guanfacine,Extended Release, An Investigational Nonstimulant Medication Filed,for the Treatment of ADHD in Children and Adolescents 8In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 2In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 3In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 4In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 5In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 6In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 7In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 8In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression 9